Business Description
Hualan Biological Bacterin Inc
No. 1, No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Compare
Compare
Traded in other countries / regions
301207.China
Description
Hualan Biological Bacterin Inc is engaged in human vaccine development, production and sales.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.76 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 0.66 | |||||
Interest Coverage | 58.78 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 9.08 | |||||
Beneish M-Score | -2.16 |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31.6 | |||||
3-Year EBITDA Growth Rate | 27.3 | |||||
3-Year EPS without NRI Growth Rate | 32 | |||||
3-Year Book Growth Rate | 46.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 77.83 | |||||
9-Day RSI | 64.75 | |||||
14-Day RSI | 58.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.74 | |||||
Quick Ratio | 2.54 | |||||
Cash Ratio | 1.75 | |||||
Days Inventory | 376.65 | |||||
Days Sales Outstanding | 238.93 | |||||
Days Payable | 308.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.37 | |||||
Forward Dividend Yield % | 0.37 | |||||
5-Year Yield-on-Cost % | 0.37 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88 | |||||
Operating Margin % | 45.49 | |||||
Net Margin % | 34.05 | |||||
ROE % | 20.93 | |||||
ROA % | 13.51 | |||||
ROIC % | 28.21 | |||||
ROC (Joel Greenblatt) % | 45.52 | |||||
ROCE % | 21.68 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.15 | |||||
PE Ratio without NRI | 31.15 | |||||
Price-to-Owner-Earnings | 67.44 | |||||
PS Ratio | 10.62 | |||||
PB Ratio | 4.28 | |||||
Price-to-Tangible-Book | 4.32 | |||||
Price-to-Operating-Cash-Flow | 70.65 | |||||
EV-to-EBIT | 26.59 | |||||
EV-to-EBITDA | 25.27 | |||||
EV-to-Revenue | 10.49 | |||||
EV-to-FCF | -89.05 | |||||
Price-to-Graham-Number | 2.44 | |||||
Price-to-Net-Current-Asset-Value | 7.64 | |||||
Price-to-Net-Cash | 18.08 | |||||
Earnings Yield (Greenblatt) % | 3.76 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,833.405 | ||
EPS (TTM) (¥) | 1.735 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 58.33 | ||
14-Day ATR (¥) | 2.310736 | ||
20-Day SMA (¥) | 50.7195 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (¥) | 38.89 - 79.78 | ||
Shares Outstanding (Mil) | 400.01 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hualan Biological Bacterin Inc Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |